{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:33:37Z","timestamp":1794648817090,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.rmed.2024.107825","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T22:59:56Z","timestamp":1727737196000},"page":"107825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung disease"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9576-6225","authenticated-orcid":false,"given":"Sebastian T.","family":"Jendrek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Schmelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Gra\u00dfhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3111-2788","authenticated-orcid":false,"given":"Jens Y.","family":"Humrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.rmed.2024.107825_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107825_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.rmed.2024.107825_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.rmed.2024.107825_bib4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"2\u20133","key":"10.1016\/j.rmed.2024.107825_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12016-008-8106-x","article-title":"Vascular disease in scleroderma","volume":"36","author":"Wigley","year":"2009","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.rmed.2024.107825_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"Suppl 5","key":"10.1016\/j.rmed.2024.107825_bib7","doi-asserted-by":"crossref","first-page":"v18","DOI":"10.1093\/rheumatology\/ken267","article-title":"Mechanisms of vascular damage in SSc\u2014implications for vascular treatment strategies","volume":"47","author":"Guiducci","year":"2008","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.rmed.2024.107825_bib8","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.rmed.2024.107825_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/ar2408","article-title":"Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors","volume":"10","author":"Hettema","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.rmed.2024.107825_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/1756-185X.12987","volume":"20","author":"Sedky","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2024.107825_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2024.107825_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","article-title":"Lipoprotein profile in limited systemic sclerosis","volume":"25","author":"Borba","year":"2005","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.rmed.2024.107825_bib13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.37358\/RC.17.4.5572","article-title":"Periodontal diseases and lipid profile in systemic sclerosis: an EUSTAR cohort experience","volume":"68","author":"Ancuta","year":"2017","journal-title":"Rev. Chim. (Bucharest)"},{"issue":"4","key":"10.1016\/j.rmed.2024.107825_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.rmed.2024.107825_bib15","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.ATV.0000094961.74697.54","article-title":"Endothelial protection by high-density lipoproteins: from bench to bedside","volume":"23","author":"Calabresi","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.rmed.2024.107825_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1172\/JCI23858","article-title":"Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling","volume":"115","author":"Assanasen","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.rmed.2024.107825_bib17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI16777","article-title":"HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner","volume":"111","author":"Gong","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.rmed.2024.107825_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ. Res."},{"issue":"16","key":"10.1016\/j.rmed.2024.107825_bib19","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/hc3901.096667","article-title":"High-density lipoproteins and endothelial function","volume":"104","author":"O'Connell","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2024.107825_bib20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3389\/fimmu.2020.01703","article-title":"Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus","volume":"11","author":"Jingquan","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2024.107825_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.rmed.2024.107825_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nut.2018.03.046","article-title":"Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis","volume":"55\u201356","author":"Siegert","year":"2018","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.rmed.2024.107825_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40618-020-01364-9","article-title":"Body composition and microvascular damage in systemic sclerosis patients","volume":"44","author":"Gigante","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.rmed.2024.107825_bib24","first-page":"822","article-title":"Fatty acid and carnitine metabolism are dysregulated in systemic sclerosis patients front immunol","volume":"11","author":"Ottria","year":"2020"},{"key":"10.1016\/j.rmed.2024.107825_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.585161","article-title":"Metabolic pattern of systemic sclerosis: association of changes in plasma concentrations of amino acid-related compounds with disease presentation","volume":"7","author":"Smolenska","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.rmed.2024.107825_bib26","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1038\/s41598-018-25992-7","article-title":"Metabolomic profile of systemic sclerosis patients","volume":"8","author":"Murgia","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2024.107825_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijcard.2017.04.024","article-title":"Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension","volume":"241","author":"Deidda","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.rmed.2024.107825_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-021-02443-9","article-title":"HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis","volume":"23","author":"Ferraz-Amaro","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.rmed.2024.107825_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/03009742.2020.1837237","article-title":"Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis","volume":"50","author":"Kim","year":"2021","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.rmed.2024.107825_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.csbj.2016.02.005","article-title":"A guide to the identification of metabolites in NMR-based metabonomics\/metabolomics experiments","volume":"14","author":"Dona","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.rmed.2024.107825_bib31","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2024.107825_bib32","first-page":"1630","article-title":"Current status of outcome measure development for clinical trials in systemic sclerosis: report from OMERACT 6","volume":"30","author":"Merkel","year":"2003","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.rmed.2024.107825_bib33","first-page":"1194","article-title":"Systemic sclerosis \u2014 continuing progress in developing clinical measures of response","volume":"34","author":"Furst","year":"2007","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.rmed.2024.107825_bib34","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.rmed.2024.107825_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.rmed.2024.107825_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00281-015-0506-4","article-title":"Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment","volume":"37","author":"Affandi","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.rmed.2024.107825_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11926-016-0565-0","article-title":"Biomarkers in scleroderma: progressing from association to clinical utility","volume":"18","author":"Ligon","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"6","key":"10.1016\/j.rmed.2024.107825_bib38","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/art.22696","article-title":"Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression","volume":"56","author":"Goh","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.rmed.2024.107825_bib39","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/kem190","article-title":"Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity","volume":"46","author":"Caramaschi","year":"2007","journal-title":"Rheumtology."},{"issue":"6","key":"10.1016\/j.rmed.2024.107825_bib40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/BOR.0000000000000113","article-title":"Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement","volume":"26","author":"Domsic","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6","key":"10.1016\/j.rmed.2024.107825_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rmed.2024.107825_bib42","article-title":"Vascular remodelling and mesenchymal transition in systemic sclerosis","volume":"2016","author":"Nicolosi","year":"2016","journal-title":"Stem Cell. Int."},{"issue":"2","key":"10.1016\/j.rmed.2024.107825_bib43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2010.133587","article-title":"Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?","volume":"70","author":"Barnes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2024.107825_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00109-011-0835-2","article-title":"Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation","volume":"90","author":"Zarbock","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"5","key":"10.1016\/j.rmed.2024.107825_bib45","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/S0006-3495(04)74347-7","article-title":"Role of cholesterol in the formation and nature of lipid rafts in planar and spherical model membranes","volume":"86","author":"Crane","year":"2004","journal-title":"Biophys. J."},{"key":"10.1016\/j.rmed.2024.107825_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-nutr-080508-141205","article-title":"The nutritional significance of lipid rafts","volume":"29","author":"Yaqoob","year":"2009","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.rmed.2024.107825_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1215039","article-title":"Metabolic fingerprinting of systemic sclerosis: a systematic review","volume":"10","author":"Morales-Gonz\u00e1lez","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.rmed.2024.107825_bib48","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"2004","journal-title":"J. Rheumatol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T22:33:40Z","timestamp":1732314820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124003007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":48,"alternative-id":["S0954611124003007"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107825","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107825"}}